Antibiotic Resistance in the Collembolan Gut Microbiome Accelerated by the Nonantibiotic Drug Carbamazepine

Yi-Fei Wang,Min Qiao,Dong Zhu,Yong-Guan Zhu
DOI: https://doi.org/10.1021/acs.est.0c03075
2020-08-20
Abstract:The effects of pharmaceuticals as emerging contaminants in soil on the gut microbiome and antibiotic resistome in nontarget soil fauna are largely elusive. In this study, we explored the composition of the bacterial community and the presence of antibiotic resistance genes (ARGs) in the gut of the model soil collembolan (<i>Folsomia candida</i>) upon antiepileptic drug carbamazepine (CBZ) and antibiotic tetracycline (TC) exposure. Results showed that, individually or in combination, exposure to TC or CBZ significantly altered the gut community structure of <i>F. candida</i>, causing some enrichment of the bacteria associated with xenobiotic metabolism, such as <i>Arthrobacter</i>, <i>Achromobacter</i>, <i>Gordonia</i>, and <i>Shinella</i>. More importantly, oral exposure to the nonantibiotic drug CBZ enhanced the abundance and diversity of ARGs in the gut of <i>F. candida</i>, especially for the beta-lactams and multidrug resistance genes. Our results revealed that the most likely hosts of ARGs in the gut of <i>F. candida</i> were Proteobacteria and Actinobacteria. The significant positive correlation between mobile genetic elements (MGEs) and ARGs indicated the potential risk of ARGs transmission in the gut of <i>F. candida</i>. Overall, the nonantibiotic CBZ is likely to disturb the gut microbiota of nontarget soil fauna such as collembolans, thereby enhancing the dissemination of ARGs.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.est.0c03075?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.est.0c03075</a>.Shannon indices and coverage (mean ± SE, <i>n</i> = 4) of bacterial community in the gut of <i>F. candida</i>; fold change of intI-1(clinic) abundance in treatments compared with control; detected number of ARGs and MGEs in the gut of <i>F. candida</i>; mortality (mean ± SE, <i>n</i> = 4) of <i>F. candida</i> exposed to individual CBZ (0.04, 0.4, 4, and 40 μg g<sup>–1</sup>), individual TC (10 μg g<sup>–1</sup>), and variable CBZ with fixed TC after 28 days; juvenile number (mean ± SE, <i>n</i> = 4) of <i>F. candida</i> in each treatment after 28 days exposure by individual CBZ (0.04, 0.4, 4, and 40 μg g<sup>–1</sup>), individual TC (10 μg g<sup>–1</sup>), and variable CBZ with fixed TC; information of 296 genes detected in the gene chip; analysis of variance for the effect of pharmaceuticals on the relative abundance and β-diversity of ARGs and MGEs in <i>F. candida</i> guts; Pearson correlation between the abundance of MGEs and ARGs; analysis of variance for the effect of pharmaceuticals on the β-diversity of <i>F. candida</i> gut microbiota; and analysis of variance for the effect of pharmaceuticals on the mortality of <i>F. candida</i> based on two-way ANOVA (<a class="ext-link" href="/doi/suppl/10.1021/acs.est.0c03075/suppl_file/es0c03075_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
environmental sciences,engineering, environmental
What problem does this paper attempt to address?